The FDA’s accelerated approval is usually based on a “surrogate marker” of effectiveness. Debate rages over the validity.
Arthur Allen | KHN.ORG
Posted inPartner Content
How Pfizer won the pandemic, reaping outsize profit and influence
The grinding two-plus years of the pandemic have yielded outsize benefits for one company — Pfizer — making it both highly influential and hugely profitable as covid-19 continues to infect tens of thousands of people and kill hundreds each day. Its success in developing covid medicines has given the drugmaker unusual weight in determining U.S. […]